malondialdehyde has been researched along with Atypical Endometrial Hyperplasia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gu, Y; Kong, L; Li, H; Liu, S; Lv, W; Qu, J; Song, C; Sun, Y; Xiao, W; Zhang, M; Zhang, T | 1 |
Cao, WX; Di, QN; Lu, L; Wang, XB; Xu, Q; Xu, R | 1 |
Serov, VN; Sterliagova, LI | 1 |
3 other study(ies) available for malondialdehyde and Atypical Endometrial Hyperplasia
Article | Year |
---|---|
Guizhi Fuling Capsule ameliorates endometrial hyperplasia through promoting p62-Keap1-NRF2-mediated ferroptosis.
Topics: Animals; Capsules; Drugs, Chinese Herbal; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogens; Female; Ferroptosis; Kelch-Like ECH-Associated Protein 1; Malondialdehyde; Medicine, Chinese Traditional; Mice, Inbred C57BL; NF-E2-Related Factor 2; Phospholipid Hydroperoxide Glutathione Peroxidase; RNA-Binding Proteins | 2021 |
Chronic low-dose exposure of nonylphenol alters energy homeostasis in the reproductive system of female rats.
Topics: AMP-Activated Protein Kinases; Animals; Carnitine O-Palmitoyltransferase; Endocrine Disruptors; Endometrial Hyperplasia; Endometrium; Energy Metabolism; Estradiol; Fatty Acids; Female; Glutathione; Liver; Malondialdehyde; Metabolomics; Oogenesis; Ovary; Oxidation-Reduction; Phenols; PPAR gamma; Rats, Sprague-Dawley; Reproduction; Risk Assessment; Superoxide Dismutase | 2018 |
[Informative value of various biochemical parameters of homeostasis in the formation of endometrial cancer risk groups].
Topics: C-Peptide; Endometrial Hyperplasia; Female; Humans; Lipid Peroxidation; Malondialdehyde; Molecular Weight; Risk Factors; Toxins, Biological; Uterine Neoplasms | 1991 |